Not sure what you mean, but I'll take a stab. Heh. Hopefully Benitec can argue for slide past phase I or at least phase Ia, but I don't think that's a high probability. But if a hep b trial starts, I wonder if a good portion of restrictions can be lifted, which would help finding participants. And given Benitec would be on par with other trials with Hep B, rather than a big step behind with Hep C, hopefully more partnerships would be forthcoming. Additionally POC with TT-034 would give more positive sentiment towards AMD and other indications. We need some other indications, but I think Benitec staff has their hands full with the ones they got.
Id like to hear Hoy's thoughts.![]()
- Forums
- ASX - By Stock
- BLT
- Ann: UPDATE ON HCV CLINICAL TRIAL
Ann: UPDATE ON HCV CLINICAL TRIAL, page-21
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)